Table 2

Characteristics of patients receiving human papillomavirus testing by country

MalawiNigeriaSenegalUgandaZimbabweOverall
n (%)n (%)n (%)n (%)n (%)n (%)
Total cohort2320134416186611387315 766
Age
25–29 years381 (16)174 (13)0 (0)1219 (18)0 (0)1774 (11)
30–34 years518 (22)244 (18)366 (23)1418 (21)753 (19)3299 (21)
35–39 years574 (25)263 (20)348 (22)1416 (21)1030 (27)3631 (23)
40–44 years520 (22)248 (18)341 (21)1337 (20)1014 (26)3460 (22)
45–49 years326 (14)168 (13)298 (18)1221 (18)956 (25)2969 (19)
50–54 years0 (0)0 (0)252 (16)0 (0)0 (0)252 (2)
Missing1 (0)247 (18)13 (1)0 (0)120 (3)381 (2)
Marital status
Married0 (0)0 (0)1455 (90)4100 (62)0 (0)5555 (35)
Single0 (0)0 (0)163 (10)1880 (28)0 (0)2043 (13)
Missing2320 (100)1344 (100)0 (0)631 (10)3873 (100)8168 (52)
Previously screened for cervical cancer
No0 (0)1247 (93)1118 (69)5897 (89)1373 (35)9635 (61)
Yes0 (0)4 (0)500 (31)714 (11)2499 (65)3717 (24)
Missing2320 (100)93 (7)0 (0)0 (0)1 (0)2414 (15)
HIV status
Positive2320 (100)1344 (100)28 (2)6611 (100)3873 (100)14 176 (90)
Negative0 (0)0 (0)1159 (72)0 (0)0 (0)1159 (7)
Unknown0 (0)0 (0)431 (27)0 (0)0 (0)431 (3)
Sample collection method
Self598 (26)794 (59)1003 (62)6611 (100)0 (0)9006 (57)
Clinician1649 (71)438 (33)615 (38)0 (0)3873 (100)6575 (42)
Missing73 (3)112 (8)0 (0)0 (0)0 (0)185 (1)
Testing model
Hub1939 (84)0 (0)1023 (63)4551 (69)0 (0)7513 (48)
Spoke381 (16)0 (0)595 (37)0 (0)0 (0)976 (6)
Centralised0 (0)1344 (100)0 (0)2060 (31)3873 (100)7277 (46)